Cargando…

Quality of Life and Supportive Care in Multiple Myeloma

Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cömert, Melda, Güneş, Ajda Ersoy, Şahin, Fahri, Saydam, Güray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878535/ https://www.ncbi.nlm.nih.gov/pubmed/24385802 http://dx.doi.org/10.4274/Tjh.2012.0192

Ejemplares similares

Extramedullary Relapse in a CML Patient after Allogeneic Stem Cell Transplantation
por: Yilmaz, Asu Fergun, et al.
Publicado: (2017)

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Soyer, Nur, et al.
Publicado: (2017)

PB1937: A RARE, DIFFICULT- TO- DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE
por: Tüzün, Betül Kübra, et al.
Publicado: (2023)

Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

PB2652: EVALUATION OF 6 CASES WITH FXIII DEFICIENCY: SINGLE CENTRE EXPERIENCE
por: Sahin, Fahri, et al.
Publicado: (2023)

PB2645: HEMATURIA IN ADULT HAEMOPHILIC INDIVIDUALS: IS THE HEMAOPHILIA THE ONLY CAUSE OF HEMATURIA? A SINGLE CENTRE EXPERIENCE FOR A DECADE
por: Tüzün, Betül Kübra, et al.
Publicado: (2023)

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Soyer, Nur, et al.
Publicado: (2017)

Sleeve Gastrectomy in a Severe Hemophilia A Patient: One of the Very Rare Cases
por: Davulcu, Eren Arslan, et al.
Publicado: (2020)

Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma
por: Tengiz, Istemihan, et al.
Publicado: (2005)

Metastatic Pulmonary Calcinosis and Leukocytoclastic Vasculitis in a Patient with Multiple Myeloma
por: Çağırgan, Seçkin, et al.
Publicado: (2012)

Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia
por: Baran, Yusuf, et al.
Publicado: (2012)

Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish
por: Mehrekula Demirci, Zuhal, et al.
Publicado: (2023)

Evidence-based supportive care in multiple myeloma
por: Qureshi, Anum, et al.
Publicado: (2020)

Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
por: Patir, Pusem, et al.
Publicado: (2015)

Individual quality of life in patients with multiple myeloma
por: Dürner, Julia, et al.
Publicado: (2013)

Review of health-related quality of life data in multiple myeloma patients treated with novel agents
por: Sonneveld, P, et al.
Publicado: (2013)

Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care
por: Bugos, Kelly G., et al.
Publicado: (2012)

Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
por: Pozzi, Samantha, et al.
Publicado: (2021)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Hemophagocytic Lymphohistiocytosis in Adults: Low Incidence of Primary Neoplasm as a Trigger in a Case Series from Turkey
por: Arslan, Ferhat, et al.
Publicado: (2018)

Multiple Myeloma in 2023 Ways: From Trials to Real Life
por: Fazio, Manlio, et al.
Publicado: (2023)

Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma
por: Balderas-Peña, Luz-Ma-Adriana, et al.
Publicado: (2019)

Patient-Reported Outcomes and Assessment of Quality of Life: A Focus on Multiple Myeloma
por: Fragola, Maryann
Publicado: (2020)

Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
por: Delforge, Michel, et al.
Publicado: (2022)

Quality of life assessment & out-of-pocket expenditure in multiple myeloma: An observational study
por: Mathew, Anisha, et al.
Publicado: (2021)

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma
por: O’Donnell, Elizabeth K., et al.
Publicado: (2022)

Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
por: Sarıman, Melda, et al.
Publicado: (2019)

Multiple myeloma/hypercalcemia
por: Oyajobi, Babatunde O
Publicado: (2007)

Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019)

Integrins in multiple myeloma
por: Hosen, Naoki
Publicado: (2020)

Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020)

Health-related quality of life in first-ever stroke patients
por: Gurcay, Eda, et al.
Publicado: (2009)

Biological Background of Resistance to Current Standards of Care in Multiple Myeloma
por: Mogollón, Pedro, et al.
Publicado: (2019)

Report on Three Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Bülbül, Hale, et al.
Publicado: (2018)

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STUDY OF REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Delforge, M., et al.
Publicado: (2022)

Hospitalization at the end of life in patients with multiple myeloma
por: Abbasi, Saqib, et al.
Publicado: (2021)

Supportive Care in Older Lymphoma Patients to Reduce Toxicity and Preserve Quality of Life
por: Massaro, Fulvio, et al.
Publicado: (2023)

Curability of Multiple Myeloma
por: Alexanian, Raymond, et al.
Publicado: (2012)

Multiple Myeloma and Diabetes
por: Issa, Zeinab A., et al.
Publicado: (2011)

Smoldering Multiple Myeloma
por: Gao, Minjie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_td8nchnllem0m2jv8drsr55ija